Please note, this OEL/ADE monograph also applies to alpha-methyltryptamine hydrochloride (CAS RN 879-36-7). Alpha-methyltryptamine (also known as AMT) is a tryptamine derivative that shares many pharmacological similarities with those of schedule I hallucinogens such as alphaethyltryptamine, N,N-dimethyltryptamine, psilocybin, methylene-dioxymethamphetamine (MDMA), and lysergic acid diethylamide (LSD). Since 1999, AMT has become popular among drug abusers for its hallucinogenic-like effects. In the 1960s, following extensive clinical studies on AMT as a possible antidepressant drug, it was concluded that AMT was a toxic substance that can produce psychosis. There are no currently approved medical uses for alpha-methyltryptamine.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Alpha-Methyltryptamine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.